作者
Katja Zeppenfeld, Jacob Tfelt-Hansen, Marta De Riva, Bo Gregers Winkel, Elijah R Behr, Nico A Blom, Philippe Charron, Domenico Corrado, Nikolaos Dagres, Christian De Chillou, Lars Eckardt, Tim Friede, Kristina H Haugaa, Meleze Hocini, Pier D Lambiase, Eloi Marijon, Jose L Merino, Petr Peichl, Silvia G Priori, Tobias Reichlin, Jeanette Schulz-Menger, Christian Sticherling, Stylianos Tzeis, Axel Verstrael, Maurizio Volterrani
发表日期
2022/10/21
来源
European heart journal
卷号
43
期号
40
页码范围
3997-4126
出版商
Oxford University Press
简介
4004 ESC Guidelines label use of medication should be limited to situations where it is in the patient’s interest to do so, with regard to the quality, safety, and efficacy of care, and only after the patient has been informed and has provided consent;(2) country-specific health regulations, indications by governmental drug regulatory agencies, and the ethical rules to which health professionals are subject, where applicable.
引用总数
学术搜索中的文章
K Zeppenfeld, J Tfelt-Hansen, M De Riva, BG Winkel… - European heart journal, 2022
